Jump to Main Content
Separation and Characterization of New Forced Degradation Products of Macitentan: A Dual Endothelin Receptor Antagonist
- Thummar, Mohit, Swain, Debasish, Gananadhamu, S.
- Chromatographia 2018 v.81 no.3 pp. 525-531
- acetonitrile, antagonists, drug evaluation, drugs, endothelin receptors, guidelines, high performance liquid chromatography, hypertension, ionization, mass spectrometry
- Macitentan (MCT) is an endothelin receptor antagonist used for the treatment of pulmonary arterial hypertension. In the present study, MCT was subjected to forced degradation as per ICH guidelines. The drug degraded extensively in acidic, basic as well as neutral hydrolytic conditions and seven degradation products (DPs) were formed. All these DPs were selectively separated using high-performance liquid chromatography (HPLC) with a stationary phase of Inertsil C₁₈ column (150 × 4.6 mm, 5 μm) and a mobile phase consisting of gradient mixture of 0.02% trifluoroacetic acid (TFA) and acetonitrile (ACN). The developed HPLC method was transferred to LC–ESI–QTOF–MS/MS for identification of DPs. The final mass spectrometric conditions were optimized for better ionization of drug and DPs with optimum mass signal sensitivity. All the formed DPs were new and well separated with sufficient resolution. The developed HPLC method was validated as per ICH-guidelines and can be used in drug testing labs for determination of quality of MCT in bulk and finished formulations.